DERMATA THERAPEUTICS, INC. Net Cash Provided by (Used in) Discontinued Operations
DERMATA THERAPEUTICS, INC. (DRMA) reported Net Cash Provided by (Used in) Discontinued Operations of $7.00 million for the 9-month period ending 2022-09-30, per its 10-Q filed 2022-11-10.
Discontinued › Cash Flow › Other Cash Flow Items
us-gaap:NetCashProvidedByUsedInDiscontinuedOperations · last filed 2022-11-10
- DERMATA THERAPEUTICS, INC. net cash provided by (used in) discontinued operations for the quarter ending 2022-09-30 was $2.60M.
- DERMATA THERAPEUTICS, INC. net cash provided by (used in) discontinued operations for the quarter ending 2022-06-30 was $1.80M.
- DERMATA THERAPEUTICS, INC. net cash provided by (used in) discontinued operations for the quarter ending 2022-03-31 was $2.60M.
- DERMATA THERAPEUTICS, INC. net cash provided by (used in) discontinued operations for the quarter ending 2021-12-31 was $1.80M.
- DERMATA THERAPEUTICS, INC. net cash provided by (used in) discontinued operations for fiscal 2020 was $4.00M.
| Period end | Net Cash Provided by (Used in) Discontinued Operations 3 month | Net Cash Provided by (Used in) Discontinued Operations 6 month | Net Cash Provided by (Used in) Discontinued Operations 9 month | Net Cash Provided by (Used in) Discontinued Operations 12 month |
|---|---|---|---|---|
| 2022-09-30 | $2.60M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-10 | $4.40M derived: sum of 2 quarters · filed 2022-11-10 | $7.00M 10-Q · filed 2022-11-10 | $8.80M derived: sum of 4 quarters · filed 2022-11-10 |
| 2022-06-30 | $1.80M derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-15 | $4.40M 10-Q · filed 2022-08-15 | $6.20M derived: sum of 3 quarters · filed 2022-11-10 | |
| 2022-03-31 | $2.60M 10-Q · filed 2022-05-16 | $4.40M derived: sum of 2 quarters · filed 2022-11-10 | ||
| 2021-12-31 | $1.80M derived: 10-Q 12 month − 10-Q 9 month · filed 2022-11-10 | $5.70M 10-Q · filed 2022-11-10 | ||
| 2021-09-30 | $3.90M 10-Q · filed 2021-11-15 | |||
| 2020-12-31 | $4.00M 10-K · filed 2022-03-28 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| REVIVA PHARMACEUTICALS HOLDINGS, INC. (RVPH) | United States | $0.005B | |
| Cadrenal Therapeutics, Inc. (CVKD) | United States | $0.004B | -0.90 |
| Lakewood-Amedex Biotherapeutics Inc. (LABT) | United States | $0.004B | |
| AMARIN CORP PLC\UK (AMRN) | $0.005B | -247.24 | |
| Processa Pharmaceuticals, Inc. (PCSA) | United States | $0.005B | |
| 60 DEGREES PHARMACEUTICALS, INC. (SXTP) | United States | $0.004B | -0.59 |
| Xenetic Biosciences, Inc. (XBIO) | United States | $0.006B | |
| ProPhase Labs, Inc. (PRPH) | United States | $0.006B | -0.06 |
| REVELATION BIOSCIENCES, INC. (REVB) | United States | $0.004B | |
| HCW Biologics Inc. (HCWB) | United States | $0.004B | -6.15 |